Cargando…

Predictors of acarbose therapeutic efficacy in newly diagnosed type 2 diabetes mellitus patients in China

BACKGROUND: Acarbose is one of the optimal drugs for patients with the first diagnosis of type 2 diabetes mellitus (T2DM). But what kind of emerging patients has the best therapeutic response to acarbose therapy has never been reported. To this end, we investigated predictors of acarbose therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Rong, Zhao, Quanxi, Li, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580108/ https://www.ncbi.nlm.nih.gov/pubmed/36258236 http://dx.doi.org/10.1186/s40360-022-00621-2

Ejemplares similares

The Effects of Gliclazide, Metformin, and Acarbose on Body Composition in Patients with Newly Diagnosed Type 2 Diabetes Mellitus()
por: Wang, Hua, et al.
Publicado: (2013)

MARCH2: Comparative Assessment of Therapeutic Effects of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients
por: Wang, Guang, et al.
Publicado: (2014)

Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade Albuminuria
por: Pan, Qingrong, et al.
Publicado: (2018)

MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin
por: Wang, Na, et al.
Publicado: (2018)

Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes
por: Song, Lulu, et al.
Publicado: (2021)

Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial
por: Pan, Qingrong, et al.
Publicado: (2016)

Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
por: Uzui, Hiroyasu, et al.
Publicado: (2011)

Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study
por: Mo, Dan, et al.
Publicado: (2019)

Sex Hormone Binding Globulin is an Independent Predictor for Insulin Resistance in Male Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Huang, Rong, et al.
Publicado: (2023)

Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal
por: Chen, Zhong, et al.
Publicado: (2016)

Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus
por: Wu, Honghua, et al.
Publicado: (2017)

Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report
por: Zheng, Miao-yan, et al.
Publicado: (2013)

Comparison of adjunctive therapy with metformin and acarbose in patients with Type-1 diabetes mellitus
por: Ziaee, Amir, et al.
Publicado: (2017)

Effects of the addition of acarbose to insulin and non-insulin regimens in veterans with type 2 diabetes mellitus
por: Wettergreen, Sara A., et al.
Publicado: (2016)

Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China
por: Gu, Shuyan, et al.
Publicado: (2016)

Factors associated with improvement in waist-to-height ratio among newly diagnosed type 2 diabetes patients treated with acarbose or metformin: A randomized clinical trial study
por: Song, Lu-Lu, et al.
Publicado: (2020)

Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients
por: He, Ke, et al.
Publicado: (2014)

Comparison of Glucose Lowering Effect of Metformin and Acarbose in Type 2 Diabetes Mellitus: A Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2015)

Prediction of Diabetic Kidney Disease in Newly Diagnosed Type 2 Diabetes Mellitus
por: Mu, Xiaodie, et al.
Publicado: (2023)

Frequency of Retinopathy in Patients Newly Diagnosed With Type 2 Diabetes Mellitus
por: Khan, Wagmah Javed, et al.
Publicado: (2023)

Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China
por: Gu, Shuyan, et al.
Publicado: (2016)

Insulin Oedema in Newly Diagnosed Type 1 Diabetes Mellitus
por: Baş, Veysel Nijat, et al.
Publicado: (2010)

Echocardiographic Changes in Newly Diagnosed Type 2 Diabetes Mellitus Patients with and without Hypertension
por: Zhao, Zhen, et al.
Publicado: (2020)

Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus
por: Li, Willis, et al.
Publicado: (2021)

Inpatient use of metformin and acarbose is associated with reduced mortality of COVID‐19 patients with type 2 diabetes mellitus
por: Li, Jinghong, et al.
Publicado: (2021)

Effect of Acarbose on Long-Term Prognosis in Acute Coronary Syndromes Patients with Newly Diagnosed Impaired Glucose Tolerance
por: Yun, Peng, et al.
Publicado: (2016)

Chronic complications in newly diagnosed patients with Type 2 diabetes mellitus in India
por: Sosale, Aravind, et al.
Publicado: (2014)

Cardiac Autonomic Neuropathy in Newly Diagnosed Patients With Type 2 Diabetes Mellitus
por: Siddiqui, Md Sabah, et al.
Publicado: (2023)

Increased MicroRNA-146a Levels in Plasma of Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Rong, Ying, et al.
Publicado: (2013)

Development and Validation of a Risk Prediction Model for Ketosis-Prone Type 2 Diabetes Mellitus Among Patients Newly Diagnosed with Type 2 Diabetes Mellitus in China
por: Jiang, Yanjuan, et al.
Publicado: (2023)

Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study
por: Ueno, Hiroaki, et al.
Publicado: (2015)

Increasing risk of diabetes mellitus in postmenopausal women with newly diagnosed primary breast cancer
por: Wang, Chih‐Yuan, et al.
Publicado: (2019)

Impaired β Cell Function in Chinese Newly Diagnosed Type 2 Diabetes Mellitus with Hyperlipidemia
por: Ma, Yuhang, et al.
Publicado: (2014)

Betel nut chewing and incidence of newly diagnosed type 2 diabetes mellitus in Taiwan.
por: Tseng, Chin-Hsiao
Publicado: (2010)

The level of netrin-1 is decreased in newly diagnosed type 2 diabetes mellitus patients
por: Liu, Chenxiao, et al.
Publicado: (2016)

Influence of Dapagliflozin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Li, Feng-fei, et al.
Publicado: (2016)

Different Interactive Effects of Metformin and Acarbose With Dietary Macronutrient Intakes on Patients With Type 2 Diabetes Mellitus: Novel Findings From the MARCH Randomized Trial in China
por: An, Yu, et al.
Publicado: (2022)

Thyroid autoimmunity in children and adolescents with newly diagnosed type 1 diabetes mellitus
por: Jung, Eui Seok, et al.
Publicado: (2014)

Characteristics of Children with Newly Diagnosed Type 1 Diabetes Mellitus in Brunei Darussalam
por: Wee, Chun Yen, et al.
Publicado: (2023)

Food Addiction in Patients with Newly Diagnosed Type 2 Diabetes in Northeast China
por: Yang, Fan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iehvgm4hui5c27hlfn537l2ma8